Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults

NCT00130390 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT00130390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2005
Completion date
July 31, 2008
Enrollment
98 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease